TradingKey

關於 Exact Sciences Corp 公司

Exact Sciences Corporation 是一家全球先進的癌症診斷公司。該公司提供一系列用於早期癌症檢測和治療指導的產品。其產品和服務專注於篩查和精準腫瘤學測試。該公司的研發工作主要集中在三個主要領域：結直腸癌篩查、MCED 測試開發和 MRD 測試開發。該公司的產品和服務包括 Cologuard 測試、Oncotype DX 乳腺復發評分測試、Oncotype DX 乳腺 DCIS 評分測試、Oncotype DX 結腸復發評分測試和 OncoExTra 測試。該公司的旗艦篩查產品 Cologuard 測試是一種非侵入性、基於糞便的脫氧核糖核酸 (sDNA) 篩查測試，它利用多目標方法檢測與結直腸癌和癌前病變相關的 DNA 和血紅蛋白生物標誌物。Oncotype DX 乳腺復發評分測試檢查患者乳腺腫瘤組織中 21 個基因的活性。

公司簡介

公司代碼EXAS

公司名稱Exact Sciences Corp

上市日期Jan 30, 2001

成立日期1995

CEOMr. Kevin T. Conroy

員工數量6900

證券類型Ordinary Share

年結日Jan 30

公司地址5505 Endeavor Lane

城市MADISON

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編53719

電話16082845700

網址https://www.exactsciences.com/

公司代碼EXAS

上市日期Jan 30, 2001

成立日期1995

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.26K

+0.94%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

Ms. Kimberly J. (Kim) Popovits

Independent Director

16.38K

+156.47%

Mr. Aaron Bloomer

Chief Financial Officer, Executive Vice President

13.84K

--

Mr. Michael J. (Mike) Barber, M.D.

Independent Director

13.14K

+121.18%

Mr. James E. Doyle

Lead Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.26K

+0.94%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Commercial

332.50M

47.04%

Medicare Parts B & C

247.89M

35.07%

Other

74.81M

10.58%

International

51.59M

7.30%

地區USD

名稱

營收

佔比

United States (Country)

655.20M

92.70%

Outside of united states

51.59M

7.30%

業務

地區

業務USD

名稱

營收

佔比

Commercial

332.50M

47.04%

Medicare Parts B & C

247.89M

35.07%

Other

74.81M

10.58%

International

51.59M

7.30%

股東統計

更新時間: 7月23日週三

持股股東

股東類型

持股股東

佔比

Fidelity Management & Research Company LLC

12.80%

Capital World Investors

9.45%

The Vanguard Group, Inc.

9.31%

Wellington Management Company, LLP

6.63%

BlackRock Institutional Trust Company, N.A.

4.07%

Other

57.74%

持股股東

佔比

Fidelity Management & Research Company LLC

12.80%

Capital World Investors

9.45%

The Vanguard Group, Inc.

9.31%

Wellington Management Company, LLP

6.63%

BlackRock Institutional Trust Company, N.A.

4.07%

Other

57.74%

股東類型

持股股東

佔比

Investment Advisor

60.66%

Investment Advisor/Hedge Fund

28.14%

Hedge Fund

4.34%

Research Firm

2.48%

Bank and Trust

1.36%

Pension Fund

1.14%

Individual Investor

0.92%

Sovereign Wealth Fund

0.54%

Private Equity

0.36%

Other

0.05%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

1397

201.71M

106.93%

+2.11M

2025Q1

1424

199.78M

106.03%

-445.52K

2024Q4

1411

200.72M

108.09%

-225.66K

2024Q3

1375

190.82M

103.28%

-5.17M

2024Q2

1358

185.25M

100.40%

+6.59M

2024Q1

1347

168.41M

92.78%

-6.10M

2023Q4

1356

165.31M

91.41%

-11.01M

2023Q3

1337

167.70M

92.83%

-6.22M

2023Q2

1354

166.38M

92.24%

-10.65M

2023Q1

1343

167.01M

92.90%

-8.56M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Fidelity Management & Research Company LLC

24.14M

12.8%

+5.29M

+28.03%

Mar 31, 2025

Capital World Investors

17.84M

9.45%

+297.66K

+1.70%

Mar 31, 2025

The Vanguard Group, Inc.

17.56M

9.31%

+616.59K

+3.64%

Mar 31, 2025

Wellington Management Company, LLP

12.50M

6.63%

+442.78K

+3.67%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

7.68M

4.07%

+12.62K

+0.16%

Mar 31, 2025

State Street Global Advisors (US)

6.61M

3.51%

+381.12K

+6.11%

Mar 31, 2025

T. Rowe Price Associates, Inc.

6.25M

3.32%

+631.23K

+11.22%

Mar 31, 2025

Fidelity Institutional Asset Management

3.59M

1.9%

+1.68M

+88.60%

Mar 31, 2025

Mackenzie Investments

3.28M

1.74%

+362.31K

+12.41%

Mar 31, 2025

Geode Capital Management, L.L.C.

3.27M

1.73%

+143.64K

+4.60%

Mar 31, 2025

持股ETF

更新時間: 7月6日週日

機構名稱

佔比

First Trust NYSE Arca Biotechnology Index Fund

3.97%

First Trust Nasdaq Lux Digi Health Solutions ETF

3.96%

Invesco Biotechnology & Genome ETF

3.25%

SPDR S&P Biotech ETF

2.41%

First Trust Indxx Medical Devices ETF

2.39%

Capital Group US Small and Mid Cap ETF

2.22%

Franklin Genomic Advancements ETF

2.18%

Nuveen ESG Mid-Cap Growth ETF

2.09%

iShares Health Innovation Active ETF

2.07%

ROBO Global Healthcare Technology & Innovation ETF

1.97%

First Trust NYSE Arca Biotechnology Index Fund

佔比3.97%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比3.96%

Invesco Biotechnology & Genome ETF

佔比3.25%

SPDR S&P Biotech ETF

佔比2.41%

First Trust Indxx Medical Devices ETF

佔比2.39%

Capital Group US Small and Mid Cap ETF

佔比2.22%

Franklin Genomic Advancements ETF

佔比2.18%

Nuveen ESG Mid-Cap Growth ETF

佔比2.09%

iShares Health Innovation Active ETF

佔比2.07%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.97%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Exact Sciences Corp

46.950USD

Exact Sciences Corp

46.950

概覽

公司

財務